Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
How to treat tumefactive demyelinating disease?
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
[Case report: a case of chronic inflammatory demyelinating polyneuropathy (CIDP) exacerbated by influenza vaccination].
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Stem cell therapy for central nerve system injuries: glial cells hold the key.
Increasing age at disability milestones among MS patients in the MSBase Registry.
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Anesthetic management of a parturient with neuromyelitis optica.
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.
[Marihuana and cannobinoids as medicaments].
Tysabri screening test may be unreliable
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
Epidemiology in multiple sclerosis: a pilgrim's progress.

Pages